Glutathione s-transferase M1 gene polymorphism in thai nasopharyngeal carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 6, Issue 3, 2005, Pages 270-275

  Tiwawech, Danai ^a,b   Srivatanakul, Petcharin ^a   Karalak, Anant ^a   Ishida, Takafumi ^b  

^a NATIONAL CANCER INSTITUTE   (Thailand)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

GSTM1 gene; Nasopharyngeal carcinoma; Polymorphism; Risk factor; Thailand

Indexed keywords

GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; NASOPHARYNX TUMOR; POLYMERASE CHAIN REACTION; THAILAND;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; THAILAND;

EID: 32944468440     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Armstrong RW, Imrey PB, Lye MS, et al (1998). Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer, 77, 228-35.
2. Autrup, JL, Thomassen LH, Olsen JH, Wolf H, Autrup H (1999). Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev, 8, 525-32.
3. Chen C, Nirunsuksiri W (1999). Decreased expression of glutathione S-transferase M1 in HPV16-transfected human cervical keratinocytes in culture. Carcinogenesis, 20, 699-703.
4. Cheng YJ, Chien YC, Hildesheim A, et al (2003). No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan. Cancer Epidemiol. Biomarkers Prev, 12, 179-80.
5. Deerasamee S, Martin N, Sontipong S, et al (1999). Eds. Cancer in Thailand Vol. II 1992-1994, IARC technical report, Lyon, 34, 30-2.
6. Deng ZL, Wei YP, Ma Y (2005). Polymorphism of glutathione Stransferase mu 1 and theta 1 genes and hepatocellular carcinoma in southern Guangxi, China. World J Gastroenterol, 11, 272-4.
7. EpiCalc 2000 statistical software version 1.02 (http://www.myatt.demon.co.uk/epicalc.htm).
8. Ford JG, Li Y, O'Sullivan MM, et al (2000). Glutathione Stransferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis, 21, 1971-5.
9. th edition. Philadelphia: Lippincott-Raven.
10. Gawronska-Szklarz B, Lubinski J, Klandy J, et al (1999). Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps. Exp Toxicol Pathol, 51 321-5.
11. Gao Y, Zhang Q (1999). Polymorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese. Mutat Res, 444, 441-9.
12. Golovleva I, Birgander R, Sjalander A, Lundgren E, Beckman L (1997). Interferon-alpha and p53 alleles involved in nasopharyngeal carcinoma. Carcinogenesis, 18, 645-7.
13. Heagerty AH, Fitzgerald D, Smith A, et al (1994). Glutathione Stransferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet , 343, 266-8.
14. Hayashi S, Watanabe J, Kawajiri K (1991). Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem, 110, 559- 65.
15. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600.
16. Hildesheim A, West S, De Veyra E (1992). Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma. Cancer Res, 52, 3048-51.
17. Ho CK, Lo W CH, Huang PH (1999). Suspected nasopharyngeal carcinoma in three workers with long term exposure to sulphuric acid vapour. Occup Environ Med, 56, 426-8.
18. IARC (1997). IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 70, Epstein-Barr virus and Kaposi's sarcoma herpesvirus/ human herpesvirus 8, Lyon.
19. Jeannel D, Hubert A, de Vathaire F (1990). Diet living conditions and nasopharyngeal carcinoma in Tunisia-A case-control study. Int J Cancer, 46, 421-5.
20. Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG (1995). Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J Natl Cancer Inst, 87, 902- 7.
21. Kihara M, Kihara M, Noda K (1995). Risk of smoking for squamous and small-cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis, 16, 2331-6.
22. Kietthubthew S, Sriplung H, Au WW (2001). Genetic and environmental interactions on oral cancer in Southern Thailand. Environ Mol Mutagen, 37, 111-6.
23. Kelsey KT, Spitz MR, Zuo ZF, Wiencke JK (1997). Polymorphisms in the glutathione S-transferase class _ and genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States). Cancer Cause Contr, 8, 554-9.
24. Kim WJ, Kim H, Kim CH (2002). GSTT1-null genotype is a protective factor against bladder cancer. Urology, 60, 913-8.
25. Kiyohara C, Shirakawa T, Hopkin JM (2002). Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer. Environ Health Prevent Med, 7, 47-59.
26. Kongruttanachok N, Sukdikul S, Setavarin S (2001). Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer, 1, 4-8.
27. Lallas TA, McClain SK, Shahin MS, Buller RE (2000). The glutathione S-transferase M1 genotype in ovarian cancer. Cancer Epidemiol Biomarkers Prev, 9, 587-90.
28. Lu SJ, Day NE, Degos L, et al (1990). Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature, 346, 470-1.
29. McDermott AL, Dutt SN, Watkinson JC (2001). The aetiology of nasopharyngeal carcinoma. Clinical Otolaryngology and Allied Sciences, 26, 82-90.
30. Mirabelli MC, Hoppin JA, Tolbert PE, et al (2000). Occupational exposure to chlorophenol and the risk of nasal and nasopharyngeal cancers among U.S. men aged 30 to 60. Am J Ind Med, 37, 532-41.
31. Mutirangura A (2001). Serum/plasma viral DNA: mechanisms and diagnostic applications to nasopharyngeal and cervical carcinoma. Ann N Y Acad Sci, 945, 59-67.
32. Nam JM, McLaughlin JK, Blot WJ (1992). Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among U.S. whites. J Natl Cancer Inst, 84, 619-22.
33. Nazar-Stewart V, Vaughan TL, Burt RD, et al (1999). Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 8, 547-51.
34. Parkin DM, Whelan SL, Ferlay J, et al (1997). Eds. Cancer incidence in five continents. Vol. VI, IARC Scientific Pupblications, Lyon, 143, 814-5.
35. Setiawan VW, Zhang ZF, Yu GP, et al (2000). GSTT1 and GSTM1 null genotypes and risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev, 9, 73-80.
36. Srivastava DS, Kumar A, Mittal B, Mittal RD (2004). Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Arch Toxicol, 78, 430-4.
37. Sweeney C, Nazar-Stewart V, Stapleton PL, Eaton DL, Vaughan TL (2003). Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomarkers Prev, 12, 527-33.
38. Spurdle AB, Webb PM, Purdie DM, et al (2001). Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis, 22, 67-72.
39. Sierra-Torres CH, Au WW, Arrastia CD, et al (2003). Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environ Mol Mutagen, 41, 69-76.
40. Strange RC, Jones PW, Fryer AA (2000). Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett, 112/113, 357-63.
41. Tiwawech D, Srivatanakul P, Karaluk A, et al, (2003). Significance of Plasma IgA and IgG Antibodies to Epstein-Barr Virus Early and Viral Capsid Antigens in Thai Nasopharyngeal Carcinoma. Asian Pacific J Cancer Prev, 4, 113-8.
42. Tune CE, Liavaag PG, Freeman JL, et al (1999). Nasopharyngeal brush biopsies and detection of nasopharyngeal cancer in a high-risk population. J Natl Cancer Inst, 91, 796-800.
43. Van der Hel OL, Peeters PH, Hein DW, et al (2003). NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. Pharmacogenetics, 13, 399-407.
44. Vaughan TL, Stewart PA, Teschke K, et al (2000). Occupational exposure to formaldehyde and wood dust and nasopharyngeal cancer. Occup Environ Med, 57, 376-84.
45. Wolf H, zur Hausen H, Becker V (1973). EB virus genomes in epithelial nasopharyngeal carcinoma cells. Nature, 244, 245- 7.
46. Zheng T, Holford TR, Zahm SH, et al (2003). Glutathione Stransferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk. Br J Cancer, 88, 58-62.
47. Zong YS, Sham JS, Ng MH, et al (1992). Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer, 69, 3-7.